World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
10224
World Ranking
3969
National Ranking
354

Andrew M. L. Lever publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Andrew M. L. Lever sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 228 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Andrew M. L. Lever D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew M. L. Lever sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 54 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Andrew M. L. Lever is affiliated with the University of Cambridge in the United Kingdom. Their research spans multiple areas broadly within Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology, with a total of 25, 23, and 16 publications in these fields respectively.

The scientist's work covers key subfields including Molecular Biology, Infectious Diseases, Virology, Ocean Engineering, and Genetics. Research topics of focus include HIV Research and Treatment, RNA Interference and Gene Delivery, SARS-CoV-2 and COVID-19 Research, Cellular transport and secretion, CRISPR and Genetic Engineering, Virus-based gene therapy research, and Drilling and Well Engineering.

Andrew M. L. Lever has contributed to several notable papers, including:

  • Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial, 2020, The Lancet
  • Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70, 2021, SSRN Electronic Journal
  • The Interplay between ESCRT and Viral Factors in the Enveloped Virus Life Cycle, 2021, Viruses
  • ESCRT-II functions by linking to ESCRT-I in human immunodeficiency virus-1 budding, 2020, Cellular Microbiology

The frequent co-authors associated with their publications include:

  • Julia C. Kenyon
  • Sarah Fidler
  • John Frater
  • Bo Meng
  • Wolfgang Stöhr

Andrew M. L. Lever has published extensively in various research venues. The most frequent publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • Zenodo (CERN European Organization for Nuclear Research)
  • Nature
  • UNC Libraries

The research output reflects a multidisciplinary approach spanning molecular and clinical aspects of infectious diseases, specifically focusing on viral pathogens such as HIV and SARS-CoV-2. Their work also explores cellular mechanisms related to virus-host interactions and gene delivery technologies, highlighting cross-disciplinary connections with genetic engineering and viral therapies.

Best Publications

  • HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation

    Ravindra K. Gupta;Sultan Abdul-Jawad;Laura E. McCoy;Hoi Ping Mok

  • Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

    A Lever;H Gottlinger;W Haseltine;J Sodroski

  • Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.

    Bo Meng;Steven A Kemp;Steven A Kemp;Guido Papa;Rawlings Datir

  • The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.

    G. P. Harrison;A. M. L. Lever

  • HIV Gag polyprotein: processing and early viral particle assembly

    Neil M. Bell;Andrew M.L. Lever

  • Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology.

    S. C. Knight;J. Farrant;A. Bryant;A. J. Edwards

  • Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin

    A.M.L Lever;D Brown;A.D.B Webster;H.C Thomas

  • Rotaviruses Associate with Cellular Lipid Droplet Components To Replicate in Viroplasms, and Compounds Disrupting or Blocking Lipid Droplets Inhibit Viroplasm Formation and Viral Replication

    Winsome Cheung;Michael Gill;Alessandro Esposito;Clemens F. Kaminski

  • Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector

    M Poznansky;A Lever;L Bergeron;W Haseltine

  • Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

    D H Gabuzda;A Lever;E Terwilliger;J Sodroski

  • Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70

    Steven Kemp;Steven Kemp;Bo Meng;Isabella Ferreira;Rawlings Datir

  • Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof

    Joseph G. Sodroski;William A. Haseltine;Mark Poznansky;Andrew Lever

  • Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70

    S.A. Kemp;B. Meng;I.A.T.M. Ferriera;Rawlings Datir

  • HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

    Massimo Pignatelli;Jenny Waters;Dave Brown;Andrew Lever

  • Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life.

    Tadashi Ikeda;Andrew M. L. Lever;Howard C. Thomas

  • Nonreciprocal Packaging of Human Immunodeficiency Virus Type 1 and Type 2 RNA: a Possible Role for the p2 Domain of Gag in RNA Encapsidation

    Jane F. Kaye;Andrew M. L. Lever

  • ALPHA-INTERFERON THERAPY FOR NON-A, NON-B HEPATITIS TRANSMITTED BY GAMMAGLOBULIN REPLACEMENT THERAPY

    B.J. Thomson;A.M.L. Lever;M. Doran;A.D.B. Webster

  • Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

    J. H. Richardson;L. A. Child;A. M. L. Lever

  • Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site.

    Geoffrey P. Harrison;Matthew S. Mayo;Eric Hunter;Andrew M. L. Lever

  • HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET.

    Emma Poole;Padraig Strappe;Hoi-Ping Mok;Ray Hicks

Frequent Co-Authors

Joseph Sodroski
Joseph Sodroski Harvard Medical School
Eric Hunter
Eric Hunter Emory University
Mark A. Wainberg
Mark A. Wainberg McGill University
Mark R. Wills
Mark R. Wills University of Cambridge
Heinrich G. Göttlinger
Heinrich G. Göttlinger University of Massachusetts Chan Medical School
Graeme J. M. Alexander
Graeme J. M. Alexander University College London
Ben Berkhout
Ben Berkhout University of Amsterdam
John Frater
John Frater University of Oxford
Michael J. Gait
Michael J. Gait MRC Laboratory of Molecular Biology
Paul D. Griffiths
Paul D. Griffiths University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology can open doors to diverse healthcare careers, many of which can be pursued online. For those interested in the organizational side of healthcare, exploring the health information management job description and salary provides valuable insights into this growing field. Professionals manage patient data and improve healthcare efficiency, making it a great complement to a scientific background.

If you want to advance your career through formal education, several online health information management degree programs cahiim accredited offer flexible, recognized pathways. These programs ensure quality and prepare students for certification and leadership roles.

For those aiming for quicker entry into the healthcare administrative sector, consider a fast track medical billing and coding certificate online. This certification provides essential skills for processing healthcare claims and can complement microbiology knowledge in clinical settings.

More broadly, numerous online healthcare programs are available, ranging from certificates to degrees, designed for those seeking flexible learning options in healthcare. These pathways support career growth and specialization within medical and scientific fields connected to microbiology.

Best Scientists Citing Andrew M. L. Lever

Trending Scientists

Recently Published Articles